“Yes, today was the original day they gave me,” Jolene told the Toronto Sun on Wednesday from her Regina home where she ...

He told me, ‘We will get you better.’ That’s what you want to hear when you’re having a procedure.” Dr. Weber, who has ...

Patients with primary hyperparathyroidism are at risk for long-term cardiometabolic complications, which may be partially mitigated by parathyroidectomy.

“We are pleased to share this data reinforcing the benefits of long-term treatment with TransCon PTH on renal function,” said Aimee Shu, M.D., Executive Vice President of Endocrine & Rare Disease ...

COPENHAGEN, Denmark, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its data showing sustained improvements in renal function, continued normalization of ...

Only two days after Bridgebio Pharma Inc. impressed investors with data from BBP-418 in limb-girdle muscular dystrophy type 2I/R9, the company was back at it again, this time reporting positive ...

- 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5 days of encaleret treatment initiation compared to 0% ...

TAMPA, FL, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- At the Norman Parathyroid Center, one alarming trend has become clear: more patients than ever are ...

TAMPA, Fla., July 22, 2025 /PRNewswire/ -- In honor of Parathyroid Awareness Month, the Norman Parathyroid Center at the Hospital for Endocrine Surgery is proud to announce a national collaboration ...